The 3 Stage Framework for GLP-1Associated Hair Loss 7 days ago 9 min read An evidence-informed clinical perspective based on Desai et al.s call for further investigation Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed the management of obesity and type 2 diabetes
(You can purchase smaller syringes)
Blood sugar control advantages One small but noteworthy crossover study compared morning versus evening semaglutide dosing and found approximately 15% lower post-prandial glucose levels with pre-8am administration
Despite its initial success, Byetta, derived from Gila monster venom, was less convenient and offered more modest weight loss compared to todays GLP-1 drugs
Zhu H, Zhou L, Wang Q, Cai Q, Yang F, Jin H, Chen Y, Song Y, Zhang C (2023) Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort
in this case discontinue Trulicity/dulaglutide and seek medical advice Acute kidney injury, monitor the renal function in patients with renal impairment and report severe gastrointestinal reactions Severe gastrointestinal disease, as usage may sometimes be associated with severe gastrointestinal reactions
